UNIVERSAL CITY, Calif. And TORONTO – The made-in-Canada hit medical drama Transplant, is returning for a second season, NBC announced today.
NBC acquired the series earlier this year after an excellent run here on CTV.
The show centers on Dr. Bashir “Bash” Hamed (Hamza Haq), a Syrian doctor with battle-tested skills in emergency medicine who fled his country with his younger sister, Amira. Together they struggle to build a new life in Canada as Bash strives to rebuild his career in medicine.
In its first season on NBC, Transplant averaged a 0.7 rating in adults 18-49 and pulled in 5.7 million viewers overall in “live plus seven day” Nielsens, with the premiere having grown to a 1.8 in 18-49 with digital and linear viewing, says the press release.
“Transplant has scored as one of television’s most time-shifted shows through its NBC run, with each of its first seven original telecasts ranking as the #1 drama of the week in ‘live plus three day’ lift,” adds the release.
In linear and digital viewing to date, Transplant is averaging 7.7 million total viewers, more than doubling its 3.5 million “live plus same day” performance.
In its first season on CTV, it was the most-watched Canadian original series and saw audience growth as the season progressed.
The show was created by Joseph Kay, who served as executive producer on season one along with Jocelyn Deschenes, Bruno Dube, Randy Lennox, Virginia Rankin, Jeremy Spry and Tara Woodbury.
Developed at CTV, Transplant is produced by Sphere Media in association with CTV and NBCUniversal International Studios, a division of Universal Studio Group. NBCUniversal Global Distribution handles worldwide distribution for the series.
